DNLI:NASDAQ
Denali Therapeutics Inc
$18.41
arrow_downward
-1.34%(-0.25) 1D
$18.49
arrow_upward
+0.43% (+0.080)bedtimeAfter hours
Closed: Oct 23, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DNLI...
Open
$18.49
High
$18.50
Low
$18.00
Mkt. cap
2.94B
Avg. vol.
1.91M
Volume
1.01M
52-wk high
$27.30
52-wk low
$13.80
EPS
-$2.84
Beta
1.02
Shares outstanding
159.85M
No. of employees
507
Open
$18.49
High
$18.50
Low
$18.00
Mkt. cap
2.94B
Avg. vol.
1.91M
Volume
1.01M
52-wk high
$27.30
52-wk low
$13.80
EPS
-$2.84
Beta
1.02
Shares outstanding
159.85M
No. of employees
507
News stories
From web sources and news partners
www.marketscreener.com
·
3 days ago
Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026
About Denali Therapeutics Inc
CEO-
Employees507
Founded2013
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitedenalitherapeutics.com